The dedicated, market facing global event for the synbio sector

Building on the successful launch event in 2019, we will once again be connecting synbio investors, academics and innovators to commercial end market customers across a variety of sectors. Across three days in Amsterdam, SynBio Markets 2020 will link science and technology to business and is committed to turning potential into profit.

Key themes for 2020

This year’s event has a renewed focus on end-user applications, with a number of brands speaking and attending to learn and showcase how synthetic biology can create and support, new and better products.
But beyond profit, in year beset with challenges we are going to highlight how synbio can help mitigate some of the effects of climate change, and bring smarter medical support and testing to the public more quickly.

Investment and commercial models are essential to success, so we will be offering a clear focus on those applications, technologies and tools that are most in demand as well as offering practical advice and insights from those with the resources to support them. This event will support you in making those connections with partners and investors from all over the world who can drive your business forward.

Befitting an industry rooted in innovation, we will deliver sessions from industry leaders detailing what their science and technology has delivered and how they’ve developed it. They will offer a ‘real world’ perspective on their projects and products, with a unique insight into the challenges they’ve overcome and the future opportunities they are focused on.

Agenda At A Glance

Showcasing the most innovative synthetic biology start-ups

Bio Stars

The 2019 speakers included...


The 2019 sponsors included...

  • At Intrexon, we see synthetic biology as being the greatest industrial vector in all of time. The applications and potential are wide ranging and we are looking forward to sharing some of our innovations at SynBio Markets
    Randal “RJ” Kirk
  • Synthetic biology is one of our focus areas of research. The market is growing rapidly and increasing venture capital investments are directed at start-up companies in the space, some of which are our partners. We are pleased to see this event being arranged
    Jari Rautio
  • We are energized by the advances within synbio both in protein design and strain engineering. We believe that it has the potential to disrupt the status quo and address the pressing global challenges of feeding 9 billion people by 2050, improving health, and addressing the environmental challenges.
    Leigh Fritz
  • Tecan is particularly excited about the growing impact of synbio in drug discovery. We provide solutions to automate a wide range of processes used in synbio and are very keen on exchanging with the community to better support the overall research/manufacturing efforts through automation.
    Luca Valeggia
  • I am looking forward to this conference. We have always had a big conference in this space in the US, but not in Europe. I have been looking for a similar type of event to happen in Europe.
    Thomas Grotkjær
  • Synthetic biology in Europe is extremely exciting. A lot of start-ups are developing interesting solutions. So, a conference in Europe is highly impactful, allowing the industry to exchange information, meet partners and investors, and help build the European synbio community.
    Josko Bobanovic